ORs for 25(OH)D deficiency | ||||
Crude OR# (95% CI) | Adjusted OR¶ (95% CI) | p-value | ||
Age years | ||||
<17 | 70 (9.6) | 0.54 (0.30–0.98) | 0.59 (0.25–1.39)+ | 0.229 |
17–29 | 211 (29.0) | 1.44 (0.98–2.10) | 1.18 (0.74–1.88)+ | 0.482 |
30–39 | 218 (30.0) | 1.0 (baseline) | 1.0 (baseline) | |
40–49 | 111 (15.3) | 0.92 (0.57–1.46) | 1.05 (0.57–1.91)+ | 0.88 |
50–59 | 54 (7.4) | 1.08 (0.59–1.97) | 1.33 (0.64–2.78)+ | 0.45 |
≥60 | 64 (8.8) | 0.48 (0.26–0.90) | 0.24 (0.08–0.69)+ | 0.009 |
Sex | ||||
Male | 406 (56.3) | 1.0 (baseline) | 1.0 (baseline) | |
Female | 315 (43.7) | 0.85 (0.54–1.34) | 0.71 (0.48–1.05)+ | 0.087 |
TB site | ||||
Pulmonary | 345 (47.3) | 1.0 (baseline) | 1.0 (baseline) | |
Extrapulmonary | 383 (52.5) | 1.77 (1.31–2.40) | 1.17 (0.78–1.76)+ | 0.45 |
HIV status | ||||
HIV-negative | 472 (64.8) | 1.0 (baseline) | 1.0 (baseline) | |
HIV-positive | 58 (8.0) | 0.44 (0.24–0.82) | 0.36 (0.18–0.71)+ | 0.004 |
Ethnicity | ||||
White | 127 (17.9) | 1.0 (baseline) | 1.0 (baseline) | |
Indian (Asian) | 105 (14.8) | 9.74 (5.31–17.85) | 10.10 (4.52–22.56)+ | <0.001 |
Black | 393 (55.5) | 3.08 (1.90–4.98) | 3.28 (1.76–6.10)+ | <0.001 |
Asian (Other) | 45 (6.4) | 1.32 (0.59–2.96) | 1.07 (0.38–2.99)+ | 0.905 |
Other | 38 (5.4) | 1.88 (0.84–4.24) | 2.28 (0.86–6.04)+ | 0.098 |
Region of birth | ||||
Africa | 170 (23.7) | 1.06 (0.67–1.67) | 0.81 (0.46–1.43)§ | 0.46 |
Horn of Africa | 132 (18.4) | 6.43 (3.96–10.43) | 6.07 (3.26–11.30)§ | <0.001 |
Americas | 26 (3.6) | 0.11 (0.14–0.81) | 0.095 (0.01–0.74)§ | 0.025 |
Asia | 61 (8.5) | 0.96 (0.50–1.83) | 0.82 (0.64–5.40)§ | 0.638 |
Indian subcontinent | 95 (18.4) | 7.16 (4.14–12.35) | 7.07 (3.26–15.34)§ | <0.001 |
Caribbean | 25 (3.5) | 1.80 (0.76–4.23) | 1.86 (0.64–5.40)§ | 0.252 |
Europe | 207 (28.9) | 1.0 (baseline) | 1.0 (baseline) | |
Horn of Africa compared to Africa | 6.06 (3.49–10.54) | 7.31 (3.96–13.49)§ | <0.001 | |
Indian subcontinent compared to Asia | 7.46 (3.29–16.93) | 11.85 (3.97–35.39)§ | <0.001 | |
Time in the UK yearsƒ | ||||
<2 years | 60 (15.0) | |||
2–5 years | 109 (27.3) | |||
6–10 years | 88 (22.1) | |||
>10 years | 142 (35.6) |
Data are presented as n (%), unless otherwise stated. 25(OH)D: 25-hydroxyvitamin D; TB: tuberculosis. #: crude odds ratio is the crude odds ratio for 25(OH)D deficiency in a given exposure category compared to the baseline group, as indicated; ¶: adjusted odds ratio is the adjusted odds ratio for 25(OH)D deficiency in a given exposure category compared to the baseline group, as indicated; +: adjusted for age, sex, TB site, HIV status and ethnicity; §: adjusted for age, sex, TB site and HIV status; ƒ: odds ratios not available.